Repository logo
 

Feasibility of Using 2,3,3,3-Tetrafluoropropene (R1234yf) as a Solvent for Solid–Liquid Extraction of Biopharmaceuticals

Published version
Peer-reviewed

Repository DOI


Change log

Authors

Suberu, J 
Yamin, P 
Cornell, R 
Sam, A 

Abstract

Tetrafluoropropene (R1234yf) is the most likely replacement for tetrafluoroethane (R134a), a widely used refrigerant, propellant, and solvent, characterized by a very high global warming potential. In this study, solvation properties of R1234yf were studied experimentally and computationally for solubility of artemisinin, a precursor to the important biopharmaceutical API, and extraction of artemisinin from biomass. R1234yf was shown to be a poorer solvent than R134a for artemisinin. COSMO-RS calculations of solvation in R1234yf suggest that the decrease in performance is likely due to entropic effects. However, R1234yf was effectively used in solid–liquid extraction of Artemisia annua. The new solvent has shown an increased selectivity to the target metabolite artemisinin. This should allow for design of more selective separation processes based on the new solvent molecule with a low global warming potential of 4 relative to CO2.

Description

Keywords

artemisinin, COSMO-RS, extraction, R1234yf, R134a, solubility

Journal Title

ACS Sustainable Chemistry & Engineering

Conference Name

Journal ISSN

2168-0485
2168-0485

Volume Title

4

Publisher

American Chemical Society
Sponsorship
EPSRC (via University of Strathclyde) (unknown)
This work was funded under iCON feasibility projects scheme of EPSRC “Centre for Continuous Manufacturing (CMAC)”, EP/IO33459/1. We acknowledge past funding from Medicine for Malaria Ventures for HPLC instrument and funding by University of Cambridge for the LCMS system.